Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction.

Project: Research

StatusActive
Effective start/end date15/07/1931/12/21

Keywords

  • Stroke
  • Cerebrovascular disorders
  • Clinical trial
  • Neuroscience
  • Stroke
  • Cerebrovascular disorders
  • Clinical trial
  • Neuroscience
  • Stroke
  • Cerebrovascular disorders
  • Clinical trial
  • Neuroscience